Question 1

What is complex hereditary spastic paraplegia?

Accepted Answer

Complex hereditary spastic paraplegia is a form of hereditary spastic paraplegia that occurs as part of a broader syndrome, where motor difficulties are accompanied by other neurological or systemic manifestations. Unlike the pure form of hereditary spastic paraplegia that primarily affects the long tracts of the spinal cord, the complex subtype involves additional features that may impact balance, coordination, or other organ systems. The precise genetic basis of this condition is not yet firmly established, and research continues to investigate the underlying factors contributing to its development. Most individuals appear to develop symptoms in childhood or early adulthood, although the age of onset may vary considerably from one person to another. Prevalence estimates are not clearly defined at this time, underscoring the need for further epidemiologic studies.

Question 2

What are the symptoms of complex hereditary spastic paraplegia?

Accepted Answer

The clinical presentation of complex hereditary spastic paraplegia is characterized primarily by progressive stiffness and spasticity in the lower limbs, which can lead to difficulties with gait and mobility. In many affected individuals, motor challenges are often the first noticeable signs, prompting medical evaluation when walking becomes increasingly arduous. In addition to these motor symptoms, there may be a range of other neurological features that vary widely among patients. Some individuals might experience problems with balance, coordination, or fine motor skills, while others could have subtle cognitive or sensory differences. That not all individuals experience every symptom, and the severity and combination of symptoms can differ significantly from one person to another.

Question 3

What causes complex hereditary spastic paraplegia?

Accepted Answer

The precise genetic basis of complex hereditary spastic paraplegia remains under active investigation. No specific genes have been definitively linked to this complex form of the condition, suggesting that it may be the result of multiple genetic and possibly environmental factors interacting in intricate ways. Since clear inheritance patterns have not yet been established, the condition is sometimes observed in individuals with no apparent family history of similar symptoms. Families affected by complex hereditary spastic paraplegia are encouraged to seek genetic counseling to gain insight into the possible risks and to remain updated on emerging research. As our understanding of the genetic contributions to this syndrome evolves, it is hoped that more targeted approaches to diagnosis and management will emerge. Associated genes include PI4KA, RNF170, ENTPD1, AMPD2, C19ORF12.

Question 4

How is complex hereditary spastic paraplegia diagnosed?

Accepted Answer

Diagnosing complex hereditary spastic paraplegia involves a careful clinical evaluation that considers the patient’s medical history, physical examination, and observed neurological features. Molecular genetic testing is often pursued as part of the diagnostic workup, even though a definitive genetic marker for this complex form has not yet been identified. Because there are no specific laboratory biomarkers unique to this condition, clinicians generally rely on a combination of clinical assessments and the exclusion of other neurological disorders with overlapping features. As research advances, additional diagnostic techniques may become available to further clarify the diagnosis. For now, a comprehensive evaluation by a specialist in neurology is essential to accurately identify and manage the condition.

Question 5

Are there treatments for complex hereditary spastic paraplegia?

Accepted Answer

Currently, management of complex hereditary spastic paraplegia focuses primarily on supportive care and targeted symptom management rather than on treatments specifically approved for this condition. Treatment plans are highly individualized and typically involve a multidisciplinary team, including neurologists, rehabilitation specialists, and physical therapists. Interventions may include physical and occupational therapy designed to maintain mobility and reduce muscle stiffness, as well as the use of assistive devices to improve daily function and safety. Medications may also be employed to help alleviate spasticity and discomfort, although the approach is tailored to the needs of each patient. Genetic counseling is recommended to provide families with information about potential recurrence risks and to guide long-term care planning.

Question 6

Are there clinical trials for complex hereditary spastic paraplegia?

Accepted Answer

Yes, there is currently 1 active clinical trial for complex hereditary spastic paraplegia registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 7

What complications can arise from complex hereditary spastic paraplegia?

Accepted Answer

Complications from complex hereditary spastic paraplegia can include progressive stiffness and spasticity in the lower limbs, which may lead to difficulties with walking and mobility. Additionally, some individuals may experience problems with balance, coordination, or fine motor skills. These complications can affect daily activities and may require ongoing support and therapy.

Question 8

How does complex hereditary spastic paraplegia affect daily life?

Accepted Answer

Living with complex hereditary spastic paraplegia can present challenges in daily life, particularly with mobility and physical activities. Many individuals may need to use assistive devices to help with walking and maintaining independence. Supportive care, including physical and occupational therapy, can play a crucial role in helping individuals manage their symptoms and improve their quality of life.

Question 9

What is the prognosis for someone with complex hereditary spastic paraplegia?

Accepted Answer

The prognosis for individuals with complex hereditary spastic paraplegia varies widely based on the severity of symptoms and the age at which they are diagnosed. Many people can maintain a good quality of life into adulthood, despite ongoing mobility challenges. Early intervention and access to specialized care can lead to better long-term management of the condition.

Question 10

Should families consider genetic counseling for complex hereditary spastic paraplegia?

Accepted Answer

Yes, families affected by complex hereditary spastic paraplegia are encouraged to seek genetic counseling. This can provide valuable information about potential recurrence risks and help families understand the genetic aspects of the condition. Genetic counselors can also guide families in making informed decisions about family planning and managing the condition over time.

Gene	Disorder(s)	MOI	Clinical Findings	Features of Disorder(s) Overlapping w/ENTPD1-NDD
ALDH18A1	SPG9A1 SPG9B2	ADAR	Cataracts; Gastroesophageal reflux; Motor neuronopathy; Dysarthria; Ataxia; Cognitive impairment	Cataracts; Motor neuropathy; Dysarthria; Ataxia; Cognitive impairment
ALDH3A2	Sjogren-Larrson syndrome (OMIM 270200)	AR	Congenital ichthyosis; Macular dystrophy; Leukodystrophy; Seizures	White matter abnormalities in brain; Seizures
AMPD2	SPG632 pontocerebellar hypoplasia type 9 (OMIM 615809)	AR	Short stature; Thin corpus callosum; White matter changes; Seizures; Variable neurocognitive symptoms	Brain abnormalities; Seizures; Variable neurocognitive findings
AP5Z1	SPG482	AR	Urinary incontinence; Parkinsonism; Dystonia; Thin corpus callosum; Leukodystrophy; Severe DD in infantile onset	Brain abnormalities; DD
B4GALNT1	SPG262	AR	Amyotrophy; Dysarthria; Ataxia; DD; Dystonia	Dysarthria; Amyotrophy; DD
BICD2	Spinal muscular atrophy 2A (OMIM 615290)	AD	Amyotrophy; Contractures; Weakness; Gait abnormalities	Amyotrophy; Weakness; Gait abnormalities
CYP2U1	SPG562	AR	Severe DD; Dystonia; Polyneuropathy; Calcification of basal ganglia	DD/ID; Neuropathy; Brain abnormalities
CYP7B1	SPG5A2	AR	Ataxia; Polyneuropathy; Extrapyramidal signs; MRI signs of leukodystrophy	White matter abnormalities; Neuropathy
DDHD2	SPG542	AR	Severe DD; Optic atrophy; Thin corpus callosum; Leukodystrophy	DD/ID; Brain abnormalities
ITPA	Developmental epileptic encephalopathy 35 (OMIM 616647)	AR	Cataracts; Feeding difficulties; Encephalopathy; Seizures; Delayed myelination; Abnormal T2-weighted signal intensity in posterior limb of internal capsule	Cataracts; Seizures; White matter abnormalities; Abnormal signal intensity in posterior limb of internal capsule
KIF1A	SPG302,3	ADAR	Spastic ataxia; Polyneuropathy	Spasticity; Gait abnormalities; Neuropathy
PGAP1	SPG67 (NDD w/dysmorphic features, spasticity, brain abnormalities) (OMIM 615802)	AR	Severe DD; Tremor; Agenesis of corpus callosum; Hypomyelination	DD/ID
Brain abnormalities SPG21(ACP33)	Mast syndrome (SPG21)2	AR	Ataxia; Adult-onset dementia parkinsonism; Polyneuropathy; Akinetic mutism seen in advanced cases	Neuropathy
SPG7	SPG72	ARAD	Dysarthria; Ataxia; Optic atrophy; Supranuclear palsy; Mitochondrial abnormalities on skeletal muscle biopsy	Gait abnormalities; Dysarthria SPG11
SPG11	AR	Obesity4; Nystagmus; Dysarthria; Gait abnormalities; ID; Brain abnormali...	—	—

System/Concern	Evaluation	Comment
Intellectual disability	Developmental assessment	To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education Neuromuscular
Progressive spastic paraparesis	Neurologic eval	To incl baseline brain MRI (if not already performed)1; Consider EMG/NCS2; To incl assessment of strength, gait, deep tendon reflexes, spasticity Neuropathy Epilepsy
Activities of daily living	Orthopedics/ physical medicine rehab/ PT OT eval	To incl assessment of:; Gross motor fine motor skills; Contractures, scoliosis; Mobility, ADL, need for adaptive devices; Need for PT (to improve or maintain gross motor skills) /or OT (to improve or maintain fine motor skills)
Dysarthria	Speech language assessment	—
Behavioral findings	Health care professional/ developmental pediatrician	Consider psychological /or psychiatric evals if issues are severe.
Neurocognitive regression	Psychological assessment	—
Cataracts	Ophthalmologic eval	To assess for reduced vision, best corrected visual acuity, refractive errors, strabismus, cataracts, which may require referral for subspecialty care /or low vision services
Genetic counseling	By genetics professionals3	To inform affected persons their families re nature, MOI, implications of ENTPD1-NDD to facilitate medical personal decision making Family support resources
ENTPD1-Related Neurodevelopmental Disorder: Supportive Care Manifestation/Concern	Treatment	Considerations/Other Developmental delay/
Intellectual disability	See	Spastic paraparesis/
Neuropathy	Physical medicine rehab/ PT OT	Incl stretching to help avoid contractures falls; Consider need for positioning mobility devices, disability parking placard.
Epilepsy	Standardized treatment w/ASM by experienced neurologist	Many ASMs may be effective; suggest use of broad-spectrum ASM (e.g., valproic acid).; Education of parents/caregivers1
Dysarthria	Per treating speech-language pathologist	Consider alternative means of communication.
Dysphagia	Swallow study speech therapy	Consider dietary modifications, alternative means of providing nutrition hydration if necessary, w/consideration of gastrostomy tube placement if necessary.
Behavioral findings	Treatment of behavioral findings incl combination of therapy pharmacologic treatment	Mgmt by psychologists, behavioral therapists, /or psychiatrists w/behavioral interventions /or medications as needed
Neurocognitive regression	Psychological assessment	—
Scoliosis	Orthopedics	Per treating orthopedist
Cataracts	Per treating ophthalmologist	Family/Community

Kisho

complex hereditary spastic paraplegia

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Differential Diagnosis

Clinical Guidance

Therapies Under Investigation

Clinical Trials

Recent Publications

complex hereditary spastic paraplegia

Overview

Clinical Presentation

Clinical Guidance

Diagnosis

Diagnostic Criteria

Suggestive Findings

Treatment

Management Guidelines

Prognosis

Surveillance Guidelines

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is complex hereditary spastic paraplegia?

What are the symptoms of complex hereditary spastic paraplegia?

What causes complex hereditary spastic paraplegia?

How is complex hereditary spastic paraplegia diagnosed?

Are there treatments for complex hereditary spastic paraplegia?

Are there clinical trials for complex hereditary spastic paraplegia?

What complications can arise from complex hereditary spastic paraplegia?

How does complex hereditary spastic paraplegia affect daily life?

What is the prognosis for someone with complex hereditary spastic paraplegia?

Should families consider genetic counseling for complex hereditary spastic paraplegia?

Differential Diagnosis

Clinical Guidance

Therapies Under Investigation

Clinical Trials

Recent Publications